Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors
Clinical trial NCT03373097 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03373097
- Sponsor
- Bambino Gesù Hospital and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-05
- Primary completion
- 2026-12-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.